Molecular medicine in ophthalmic care

Optometry

Volumn 80, Issue 12, 2009, Pages 695-701

  Richer, Stuart ^a,b   Stiles, William ^a   Thomas, Carla ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Dietary polyphenols; Resveratrol; RPE lipofuscin

Indexed keywords

FLAVONOID; LIPOFUSCIN; PHENOL DERIVATIVE; POLYPHENOLS; RESVERATROL; STILBENE DERIVATIVE;

AGED; ARTICLE; CAR DRIVING; CASE REPORT; CONVALESCENCE; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; HUMAN; MALE; MENTAL HEALTH; METABOLISM; METHODOLOGY; NIGHT BLINDNESS; OPHTHALMOLOGY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PIGMENT EPITHELIUM; PSYCHOLOGICAL ASPECT; RETINA; VISION;

ADMINISTRATION, ORAL; AGED, 80 AND OVER; AUTOMOBILE DRIVING; DRUG COMBINATIONS; FLAVONOIDS; HUMANS; LIPOFUSCIN; MALE; MENTAL HEALTH; NIGHT BLINDNESS; OPHTHALMOLOGY; PHENOLS; RECOVERY OF FUNCTION; RETINA; RETINAL PIGMENT EPITHELIUM; STILBENES; VISION, OCULAR;

EID: 71649092866     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.optm.2009.03.018     Document Type: Article

References (56)

1. Mariappan D., Winkler J., Parthiban V., et al. Dietary small molecules and large-scale gene expression studies: an experimental approach for understanding their beneficial effects on the development of malignant and non-malignant proliferative diseases. Curr Med Chem 13 13 (2006) 1481-1489
2. Signorelli P., and Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 16 8 (2005) 449-466
3. Chavez A., and Munoz de Chavez M. Nutrigenomics in public health nutrition: short-term perspectives. Eur J Clin Nutr 57 Suppl. 1 (2003) 97-100
4. Lamming D.W., Wood J.G., and Sinclair D.A. Small molecules that regulate lifespan: evidence for xenohormesis. Mol Microbiol 53 (2004) 1003-1009
5. Gray D.A., and Woulfe J. Lipofuscin and aging: a matter of toxic waste. Sci Aging Knowl Environ 5 (2005) 1
6. Ledda M., Barni L., Altieri L., et al. Amount and distribution of lipofuscin in nerve and satellite cells from spinal ganglia of young adult and aged rabbits. J Submicroscopic Cytology Pathology 31 (1980) 237-246
7. Feeney-Burns L., Berman E.R., and Rothman H. Lipofuscin of human retinal pigment epithelium. Am J Ophthalmol 90 (1980) 783-791
8. van der Schaft T.L., de Bruijn W.C., Mooy C.M., et al. Is basal laminar deposit unique for age-related macular degeneration?. Arch Ophthalmol 109 (1991) 420-425
9. De Jong P. Age-related macular degeneration. N Engl J Med 355 (2006) 1474-1485
10. von Rückmann A., Fitzke F.W., and Bird A.C. Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol 79 (2005) 407-412
11. Bohra L.I., Weizer J.S., Lee A.G., et al. Vision loss as the presenting sign in juvenile neuronal ceroid lipofuscinosis. J Neuroophthalmol 20 (2000) 111-115
12. Avalle L.B., Dillon J., Tari S., et al. A new approach to measuring the action spectrum for singlet oxygen production by human retinal lipofuscin. Photochem Photobiol 81 (2005) 1347-1350
13. Meyers S.M., Ostrovsky M.A., and Bonner R.F. A model of spectral filtering to reduce photochemical damage in age-related macular degeneration. Trans Am Ophthalmol Soc 102 (2004) 83-93
14. Weale R.A. Do years or quanta age the retina?. Photochem Photobiol 50 (1989) 429-438
15. Brunk U.T., and Terman A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med 33 (2002) 611-619
16. Blackett A.D., and Hall D.A. Tissue vitamin E levels and lipofuscin accumulation with age in the mouse. J Geron 36 (1981) 529-533
17. Winstanley E.K., and Pentreath V.W. Lipofuscin accumulation and its prevention by vitamin E in nervous tissue: quantitative analysis using snail buccal ganglia as a simple model system. Mech Ageing Dev 29 (1985) 299-307
18. Constantinides P., Harkey M., and McLaury D. Prevention of lipofuscin development in neurons by anti-oxidants. Virchows Arch A Pathol Anat Histopathol 409 (1986) 583-593
19. Guarnieri C., Muscari C., Manfroni S., et al. The effect of treatment with coenzyme Q10 on the mitochondrial function and superoxide radical formation in cardiac muscle hypertrophied by mild aortic stenosis. J Mol Cell Cardiol 19 (1987) 63-71
20. Murali G., Panneerselvam K.S., and Panneerselvam C. Age-associated alternations of lipofuscin membrane-bound ATPases in intracellular calcium in cortex, striatum and hippocampus of rat brain: protective role of glutathione monoester. Int J Dev Neurosci 26 (2008) 211-215
21. Savitha S., Naveen B., and Penneerselvam C. Carnitine and lipoate ameliorates lipofuscin accumulation and monoamine oxidase activity in aged rat heart. Eur J Pharmacol 574 (2007) 61-65
22. Arivazhagan P., and Panneerselvam C. Alpha-lipoic acid increases Na + K+ATPase activity and reduce lipofuscin accumulation in discrete brain regions of aged rates. Ann NY Acad Sci 1019 (2004) 350-354
23. Arockia Rani P.J., and Penneerselvam C. Carnitine as a free radical scavenger in aging. Exp Gerontol 36 (2001) 1713-1726
24. Bala K., Tripathy B.C., and Sharma D. Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions. Biogerontology 7 (2006) 81-89
25. de Freitas V., da Silva Porto P., Assuncao M., et al. Flavonoids from grape seeds prevent increased alcohol-induced neuronal lipofuscin formation. Alcohol Alcoholism 39 (2004) 303-311
26. Sundelin S.P., and Nilsson S.E. Lipofuscin-formation in retinal pigment epithelial cells is reduced by antioxidants. Free Radic Biol Med 31 (2001) 217-225
27. Schutt F., Volcker H.E., and Dithmar S. N-acetylcysteine improves lysosomal function and enhances the degradation of photoreceptor outer segments in cultured RPE cells. Klin Monatsbl Augenheilk 224 (2007) 580-584
28. Katz M.L., and Robison Jr. W.G. Lipofuscin response to the "aging-reversal" drug centrophenoxine in rat retinal pigment epithelium and frontal cortex. J Gerontol 38 (1983) 525-531
29. Dylewski D.P., Nandy S., and Nandy K. Effects of centrophenoxine on lipofuscin in the retinal pigment epithelium of old mice. Neurobiol Aging 4 (1983) 89-95
30. Kurz T., Terman A., and Brunk U.T. Autophagy, ageing and apoptosis: the role of oxidative stress and lysosomal iron. Arch Biochem Biophy 462 (2007) 220-230
31. Killilea D.W., Wong S.L., Cahaya H.S., et al. Iron accumulation during cellular senescence. Annals NY Acad Sci 1019 (2004) 365-369
32. Terman A., and Brunk U.T. Oxidative stress, accumulation of biological garbage and aging. Antioxidant Redox Signaling 8 (2006) 197-204
33. Katz M.L., Christianson J.S., Gao C.L., et al. Iron-induced fluorescence in the retina: dependence on vitamin A. Invest Ophthalmol Vis Sci 35 (1994) 3613-3624
34. Dunaief J.L. Iron induced oxidative damage as a potential factor in age-related macular degeneration: the Cogan Lecture. Invest Ophthalmol Vis Sci 47 (2006) 4660-4664
35. Terman A. Catabolic insufficiency and aging. NY Acad Sci 1067 (2006) 27-36
36. Terman A., Gustaffson B., and Brunk U.T. The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. Chemical Biological Interaction 163 (2006) 29-37
37. Yu B.P. Why calorie restriction would work for human longevity. Biogerontology 7 (2006) 179-182
38. Katz M.L., White H.A., Gao C.L., et al. Dietary restriction slows age pigment accumulation in the retinal pigment epithelium. Invest Ophthalmol Vis Sci 34 (1993) 3297-3302
39. Bergamini E., Cavallini G., Donati A., et al. The role of macroautophagy in the ageing process, anti-ageing intervention and age-associated diseases. Int J Biochem Cell Biol 36 (2004) 2392-2404
40. Borten O., Liberman A., Tuchweber B., et al. Effects of dietary restriction and metal supplementation on the accumulation of iron-laden glial inclusions in the aging rat hippocampus. Biogerontology 5 (2004) 81-88
41. Lin S.A., Defossez P.A., and Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289 (2000) 2126-2128
42. Howitz K.J., Bitterman K.T., Cohen H.Y., et al. Small molecule activators of sirtuins. extend Saccharomyces cerevisiae lifespan. Nature 425 (2003) 191-196
43. Petrukhin K. New therapeutic targets in atrophic age-related macular degeneration. Expert Opin Ther Targets 11 (2007) 625-639
44. Opipari Jr. A.W., Tan L., Boitano A.E., et al. Resveratrol-induced autophagocytosis in ovarian cancer cells. Cancer Res 64 (2004) 696-703
45. Mira L., Fernandex M.T., Santos M., et al. Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radical Research 36 (2002) 1199-1208
46. Nicholson S.K., Tucker G.A., and Brameld J.M. Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc Nutr Soc 67 (2008) 42-27
47. Liu Y., Popovich Z., and Templeton D.M. Global genomic approaches to the iron-regulated proteome. Ann Clin Lab Sci 35 (2005) 230-239
48. Everitt A.V., and Le Couteur D.G. Life extension by calorie restriction in humans. Ann NY Acad Sci 1114 (2007) 428-433
49. Amit T., Avramovich-Tirosh Y., Youdim M.D., et al. Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators. FASEB J 22 (2008) 296-305
50. Harris G, Pratt S, Richer. Food and Nutrients in Disease Management. In: Ingrid Kohlstadt I, editor. Strategies for medical doctors, section I. Conditions of the ears, eyes, nose, and mouth, age-related macular degeneration. Baltimore, MD: Johns Hopkins University. CRC Press; 2009.
51. Age-Related Macular Degeneration Study Group. Multicenter ophthalmic and nutritional age-related macular degeneration study Part 1: design, subjects and procedures. J Am Optom Assoc 67 2 (1996) 12-29
52. Age-Related Macular Degeneration Study Group. Multicenter ophthalmic and nutritional age-related macular degeneration study Part 2: antioxidant intervention & conclusions. J Am Optom Assoc 67 2 (1996) 30-49
53. Richer S.P. Part 1: A protocol for the evaluation and treatment of atrophic age-related macular degeneration. J Am Optom Assoc 70 1 (1999) 13-23
54. Richer S.P. Part 2: ARMD-Pilot (case studies) environmental intervention data. J Am Optom Assoc 70 (1999) 24-26
55. Richer S.P. Antioxidants and the eye. In: Friedlaender M.H. (Ed). International ophthalmology clinics, nutrition/CRC Press (2000), Lippincott Williams & Wilkins, Philadelphia 1-16
56. Richer S.P., Stiles W., Statkute L., et al. A placebo-controlled, double blind, randomized trial of lutein and antioxidant supplementation for the treatment of age related macular degeneration: the Lutein Antioxidant Supplementation Trial. Optometry 75 (2004) 216-230